IP Library Granted Patent US 9,217,178
Granted Patent B2
US 9,217,178 · App. 11/792,878 · Granted Dec 22, 2015

Method of nucleotide detection

Inventors: Milan Fedurco (Saffron Walden, GB); Anthony Romieu (Saffron Walden, GB); Gerardo Turcatti (Saffron Walden, GB)
Assignee: Illumina Cambridge Limited
C12Q1/6874C12Q1/6869
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,217,178
App. No.
11/792,878
Granted
Dec 22, 2015
Kind
B2
Abstract

The invention relates to an additive which can be added to buffers used in nucleotide detection processes and improved methods of nucleic acid sequencing using the additive. In particular the invention relates to use of the additive to improve the efficiency of fluorescence-based multiple cycle nucleic acid sequencing reactions.

Claims (19)

1. A method of inhibiting light-induced degradation of nucleic acids during a detection step of a nucleic acid sequencing reaction comprising the steps of:

a. incorporating one or more fluorescently labelled nucleotides into a strand of nucleic acid complementary to a template nucleic acid immobilized to a solid support;

b. irradiating said template nucleic acid in the presence of a detection buffer comprising ascorbic acid, or a salt thereof, and determining the identity of one or more of the incorporated nucleotides;

c. removing the fluorescent label from the incorporated nucleotide(s) using a chemical treatment; and

d. washing said solid support;

wherein steps a-d are repeated at least 10 times.

2. The method according to claim 1 , wherein said fluorescently labelled nucleotide is a nucleotide triphosphate.

3. The method according to claim 1 , wherein the ascorbic acid or salt thereof is present in the buffer at a concentration of at least 10 mM.

4. The method according to claim 1 , wherein the ascorbic acid or salt thereof is present in the buffer at a concentration of at least 20 mM.

5. The method according to claim 1 , wherein the ascorbic acid or salt thereof is present in the buffer at a concentration of up to 100 mM.

6. The method according to claim 1 , wherein the salt of ascorbic acid is sodium ascorbate.

7. The method according to claim 1 , wherein the buffer further comprises additional antioxidants.

8. The method according to claim 1 , wherein the buffer has a pH of about 5.5 to about 8.6.

9. The method according to claim 1 , wherein the buffer has a pH of about 7.

10. The method according to claim 1 , wherein the template nucleic acid is present in an array.

11. The method according to claim 10 , wherein the array is a clustered array.

12. The method according claim 1 , wherein steps a-d are repeated at least 16 times.

13. The method according to claim 1 , wherein said fluorescent label is attached to the one or more of the incorporated nucleotide(s) via a linker comprising a disulfide linkage.

14. The method according to claim 1 , wherein said fluorescent label is attached to the one or more of the incorporated nucleotide(s) via a linker comprising an azide.

Assignments (3)
CHANGE OF NAME Recorded Nov 30, 2011
From: SOLEXA LIMITED
To: ILLUMINA CAMBRIDGE LIMITED
Reel/Frame 027303/0675 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2008
From: FEDURCO, MILAN; ROMIEU, ANTHONY; TURCATTI, GERARDO
To: ILLUMINA CAMBRIDGE LIMITED
Reel/Frame 021400/0705 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2008
From: FEDURCO, MILAN; ROMIEU, ANTHONY; TURCATTI, GERARDO
To: SOLEXA LIMITED
Reel/Frame 021401/0248 →
Priority Claims (2)
GB 0427236.5 · Dec 13, 2004 · national
GB 0514933.1 · Jul 20, 2005 · national
Continuity (1)
Related Publication 20080280773A1 · Nov 13, 2008